Characterisation of the immune repertoire of a humanised transgenic mouse through immunophenotyping and high-throughput sequencing
eLife · 27.03.2023 · 12
DOI: 10.7554/elife.81629 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 27.03.2023. Verfasst von Eve Richardson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Antibodies, B-Lymphocytes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, Medical Research Council.
Abstract (Originalsprache)
Immunoglobulin loci-transgenic animals are widely used in antibody discovery and increasingly in vaccine response modelling. In this study, we phenotypically characterised B-cell populations from the Intelliselect Transgenic mouse (Kymouse) demonstrating full B-cell development competence. Comparison of the naïve B-cell receptor (BCR) repertoires of Kymice BCRs, naïve human, and murine BCR repertoires revealed key differences in germline gene usage and junctional diversification. These differences result in Kymice having CDRH3 length and diversity intermediate between mice and humans. To compare the structural space explored by CDRH3s in each species’ repertoire, we used computational structure prediction to show that Kymouse naïve BCR repertoires are more human-like than mouse-like in their predicted distribution of CDRH3 shape. Our combined sequence and structural analysis indicates that the naïve Kymouse BCR repertoire is diverse with key similarities to human repertoires, while immunophenotyping confirms that selected naïve B cells are able to go through complete development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom.
- Department of Statistics, University of Oxford, Oxford, United Kingdom.
- Division of Immunology, University Children's Hospital, University of Zurich, Zurich, Switzerland.
- Children's Research Center, University of Zurich, Zurich, Switzerland.
- Alchemab Therapeutics Ltd, Kings Cross, London, United Kingdom.
- Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
ORCID-Profile: Eve Richardson, Miha Kosmac, Valentin von Niederhäusern, Aleksandr Kovaltsuk, Jacob D Galson, Johannes Trück, Charlotte M Deane
Förderung
- Bill & Melinda Gates Foundation
- Medical Research Council
Zitieren
APA
Richardson, E., Binter, Š., Kosmac, M., Ghraichy, M., von Niederhäusern, V., Kovaltsuk, A., Galson, J. D., Trück, J., Kelly, D. F., Deane, C. M., Kellam, P., & Watson, S. J. (2023). Characterisation of the immune repertoire of a humanised transgenic mouse through immunophenotyping and high-throughput sequencing. eLife, 12. https://doi.org/10.7554/elife.81629
Vancouver
Richardson E, Binter Š, Kosmac M, Ghraichy M, von Niederhäusern V, Kovaltsuk A, et al. Characterisation of the immune repertoire of a humanised transgenic mouse through immunophenotyping and high-throughput sequencing. eLife. 2023;12. doi:10.7554/elife.81629
BibTeX
@article{Richardson2023,
author = {Richardson, Eve and Binter, Špela and Kosmac, Miha and Ghraichy, Marie and von Niederhäusern, Valentin and Kovaltsuk, Aleksandr and Galson, Jacob D and Trück, Johannes and Kelly, Dominic F and Deane, Charlotte M and Kellam, Paul and Watson, Simon J},
title = {Characterisation of the immune repertoire of a humanised transgenic mouse through immunophenotyping and high-throughput sequencing},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.81629}
}
EUVIMED